← FDA Drug Approvals (Drugs@FDA)
SYMTUZA
NDA · New Drug Application · Sponsor: JANSSEN PRODS · Approved 2018-07-17
Drug application
- FDA Application #
NDA210455- Application type
- New Drug Application
- Brand name
- SYMTUZA
- Generic name
- DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE
- Active ingredients
- COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- JANSSEN PRODS
- Manufacturer
- Janssen Products LP
- First approval
- 2018-07-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown